X-CELL MEDICAL COMMENCES RANDOMIZED CLINICAL TRIAL OF ESTRADIOL ELUTING STENT

X-Cell Medical, Inc. announced today that it has commenced a multinational clinical trial to study the safety and effectiveness of 17(beta)-estradiol stents coated with slow-release and moderate-release formulations, the ETHOS I Coronary Stent System. Estradiol, an approved and safe drug used in hormone replacement therapy and other indications, represents a novel and potentially safer approach to reducing restenosis in human coronary arteries.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1035961XSL_NEWSML_TO_NEWSML_WEB.xml)